Single answer
Is Amryt Pharma plc (AMYT) a buy or sell?
4starter turns market data into one clear verdict you can act on.
Create a free account to save tickers and track your signals.
Log in to turn on watchlist alerts.
What is the conclusion?
Right now our advanced algorithms say:
Do analysts agree?
We compare consensus targets with today's price.
Consensus target for Amryt Pharma plc is $14.50, which is $0.200 (1.36%) below the current price today's price.
Low target: $14.50 | High target: $14.50
Company snapshot
A quick overview of the business and its public profile.
Amryt Pharma plc a commercialstage biopharmaceutical company focuses on acquiring developing and commercializing various treatments to help improve the lives of patients with rare and orphan diseases The company provides metreleptin an adjunct to diet as replacement therapy to treat the complications of leptin deficiency in patients with congenital or acquired generalized lipodystrophy oral octreotide a longterm maintenance therapy in acromegaly patients and lomitapide an adjunct to a lowfat diet and other lipidlowering medicinal products for adults with the Homozygous familial Hypercholesteraemia Its development candidates include OleogelS10 for the cutaneous manifestations of Junctional and Dystrophic Epidermolysis Bullosa EB a rare and distressing genetic skin disorder affecting young children and adults and AP103 a preclinical gene therapy for patients with dystrophic EB The company sells its products in the Americas Europe and the Middle East Amryt Pharma plc was founded in 2015 and is headquartered in Dublin Ireland
Website: httpswwwamrytpharmacom
Rates and inflation backdrop
US inflation for September 2025 was 0.31%. Over the last 12 months, inflation is 3.02%. The 10-year yield is 4.12 and is down -0.1000 over the last 30 days.
Inflation sensitivity
Debt ratio: 0.25. Cash flow to debt ratio: 0.08. Net profit margin: -8.17%. Inflation risk score: high (0.75/1).
Dividend history check
We cannot find any recorded dividends paid in our systems.
Trading liquidity
Yes, the average daily trading liquidity for Amryt Pharma plc is $7.9M. You should therefore be able to get in and out of your positions relatively fast.
10-year return check
We cannot find data for Amryt Pharma plc 10 years ago, but if you had invested on 2019-12-31 when the price was $7.95, you would have made a profit of $6.75 per share or 84.91%.
Why this answer
We combine price momentum, volatility, and trend signals to simplify the decision to one word.
Signal engine scans price, trend, and momentum indicators.
Targets and sentiment are checked against the live quote.
We keep the output simple: buy, sell, or hold.
Analyst consensus
How Wall Street targets compare to today's price.